Observation On The Efficacy Of Huoxue Zhuanggu Decoction In Treating Residual Pain (Qi Stagnation And Blood Stasis Syndrome) After LDH Endoscopic Surger

Objective:The clinical efficacy of Huoxuezhuanggu Decoction addition and subtraction in the treatment of residual pain after percutaneous endoscopic lumbar discectomy for lumbar disc herniation(Syndrome of qi stagnation and blood stasis)was observed,which provided a clinical basis for the treatment of residual pain after percutaneous endoscopic lumbar discectomy for LDH.Methods:From January 1,2022 to December 3 1,2022,60 patients who underwent percutaneous endoscopic lumbar discectomy for lumbar disc herniation treatment in the Department of Spine of the Second Affiliated Hospital of Hunan University of Chinese Medicine were collected,and 30 patients were divided into treatment group and control group by simple randomization+"envelope method" group concealment.Starting from the first day after surgery,the treatment group took Huoxuezhuanggu Decoction addition and subtraction of Chinese medicine,and the control group took Celebrex and methylcobalamin tablets,and both groups took the drug for 14 consecutive days.The VAS score,lumbar JO A score,ODI score and quantitative points of TCM syndrome of the two groups were recorded on the first postoperative day,7 days of medication,14 days of medication and 30 days after surgery,and the overall efficacy was evaluated 30 days after surgery by combining the improvement rate of the "Diagnostic Efficacy Standards of Traditional Chinese Medicine Symptoms" and the JOA score.Results:1.General data comparison:the treatment group and the control group patients in the gender,age,course and lesion segments,the difference was not statistically significant,P>0.05,comparable.2.VAS score comparison:intra-group comparison:7 days of medication versus day 1 after surgery,14 days versus 7 days of medication,30 days after surgery and 14 days of medication,P<0.01,the difference was statistically significant;between the groups,the difference in VAS scores between the two groups before taking the drug was not statistically significant,P>0.05,which was comparable;the difference was statistically significant in comparing VAS scores at 7 days of taking the drug,P<0.05,and the VAS scores were compared at 14 days and 30 days after surgery,P>0.05,the difference was not statistically significant.3.Comparison of JOA score:Intra-group comparison:between 7 days of medication and the first day after surgery,30 days after surgery and 14 days of medication,P<0.0 1,the difference was statistically significant,compared with 7 days of taking the drug,P<0.05,the difference was statistically significant;between the groups,the difference between the two groups was not statistically significant,P>0.05,comparable;the comparison of the 7-day JOA score,P<0.0 5,the difference was statistically significant,and the comparison of the JOA score after 14 days and 30 days after the operation,the P>0.05,the difference was not statistically significant.4.Comparison of ODI score:Intra-group comparison:between 7 days of medication and the first day after surgery,14 days of medication and 7 days of medication,30 days after surgery and 14 days of medication,P<0.01,the difference was statistically significant;between groups:the ODI score comparison of the two groups before taking the drug,the difference of P>0.05 was not statistically significant,comparable;the ODI score comparison of 7 days of taking the drug,P<0.05,the difference was statistically significant,and the ODI score of 14 days of medication and 30 days after the operation,P>0.05,the difference was not statistically significant.5.Comparison of quantitative points of TCM syndrome:intra-group comparison:between 7 days of medication and the first day after surgery,between 14 days of medication and 7 days of medication,30 days after surgery and 14 days of medication,P<0.01,the difference was statistically significant;between-group comparison:the quantitative points of medical symptoms in the two groups before taking the drug,P>0.05,the difference was not statistically significant and comparable;the quantitative points of TCM symptoms were compared for 7 days of taking the drug,P>0.05,the difference was not statistically significant,and the quantitative points of TCM symptoms were compared for 14 days and 30 days after surgery,P<0.05,the difference was statistically significant.6.Comparison of overall efficacy:the total effective rate of the treatment group was 92.86%,and the total effective rate of the control group was 8 8.89%,P>0.05,the difference was not statistically significant.Conclusion:1.Oral Huoxuezhuangu decoction addition and subtraction or Celebrex+Mecobalamine tablets could effectively relieve residual pain after percutaneous endoscopic lumbar discectomy for lumbar disc herniation,improve lumbar spine dysfunction and improve patients’ quality of life.2.The short-term effect of Celebrex+Mecobalamine tablets was better than Huoxuezhuanggu Decoction addition and subtraction,but as the treatment continued,the overall efficacy of the two groups was similar.3.Huoxuezhuanggu Decoction addition and subtraction has definite curative effect on residual pain after percutaneous endoscopic lumbar discectomy for LDH and it can improve the TCM syndrome of patients,which is worthy of further clinical promotion and application.